JP2001510325A - キチナーゼ物質及び方法 - Google Patents

キチナーゼ物質及び方法

Info

Publication number
JP2001510325A
JP2001510325A JP50188998A JP50188998A JP2001510325A JP 2001510325 A JP2001510325 A JP 2001510325A JP 50188998 A JP50188998 A JP 50188998A JP 50188998 A JP50188998 A JP 50188998A JP 2001510325 A JP2001510325 A JP 2001510325A
Authority
JP
Japan
Prior art keywords
chitinase
dna
polynucleotide
seq
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP50188998A
Other languages
English (en)
Japanese (ja)
Inventor
グレイ，パトリック，ダブリュ．
Original Assignee
アイコス コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイコス コーポレイション filed Critical アイコス コーポレイション
Publication of JP2001510325A publication Critical patent/JP2001510325A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
JP50188998A 1996-06-14 1997-06-16 キチナーゼ物質及び方法 Ceased JP2001510325A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/663,618 1996-06-14
US08/663,618 US20030017570A1 (en) 1996-06-14 1996-06-14 Chitinase materials and methods
PCT/US1997/010460 WO1997047752A1 (en) 1996-06-14 1997-06-16 Chitinase materials and methods

Publications (1)

Publication Number Publication Date
JP2001510325A true JP2001510325A (ja) 2001-07-31

Family

ID=24662596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50188998A Ceased JP2001510325A (ja) 1996-06-14 1997-06-16 キチナーゼ物質及び方法

Country Status (14)

Country Link
US (2) US20030017570A1 (no)
EP (1) EP0918870A1 (no)
JP (1) JP2001510325A (no)
CN (1) CN1236393A (no)
AU (1) AU731203B2 (no)
BR (1) BR9709721A (no)
CA (1) CA2257829A1 (no)
CZ (1) CZ403598A3 (no)
HU (1) HUP0001644A3 (no)
IL (1) IL127568A0 (no)
NO (1) NO985806L (no)
PL (1) PL337060A1 (no)
SK (1) SK169798A3 (no)
WO (1) WO1997047752A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200951B1 (en) 1998-03-12 2001-03-13 Icos Corporation Chitinase chitin-binding fragments
WO2001023430A2 (en) * 1999-09-30 2001-04-05 Icos Corporation Human chitinase immunoglobulin fusion proteins
US7632654B2 (en) * 2002-04-29 2009-12-15 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Means and methods for detecting endoglycosidase activity
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
US20110070601A1 (en) * 2008-01-23 2011-03-24 Rigshospitalet Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
EP2192409B1 (en) * 2008-11-26 2014-04-23 Corning Incorporated Label independent detection biosensor composition and methods thereof
WO2011159865A2 (en) * 2010-06-16 2011-12-22 Yale University Compositions and methods for using human ykl-40 to treat acute lung injury
EP2746407A1 (en) * 2012-12-18 2014-06-25 EADS Deutschland GmbH Novel Aspergillus sp. strain NBIMCC 8735 and method of producing chitinase utilizing the same
PL235436B1 (pl) 2014-11-28 2020-08-10 Univ Jagielloński Kompleks białkowy zawierający białko G i chitynazę A, sposób wyodrębniania z roztworu wodnego chitynazy A oraz jego zastosowania
WO2018078626A1 (en) * 2016-10-27 2018-05-03 Gavish-Galilee Bio Applications, Ltd. Combination therapies including human chitinase (chit1) for the treatment of systemic fungal infection
CN109971741A (zh) * 2019-03-27 2019-07-05 大连大学 低温几丁质酶基因chiC在乳酸克鲁维酵母中的表达纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326561A (en) 1992-12-15 1994-07-05 Cornell Research Foundation, Inc. Antifungal synergistic combination of enzyme fungicide and non-enzymatic fungicide and use thereof
US5561051A (en) 1994-06-14 1996-10-01 American Cyanamid Company Screen for inhibitors of chitinase
US5928928A (en) 1995-06-07 1999-07-27 Universiteit Van Amsterdam Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
JPH11508139A (ja) 1996-03-29 1999-07-21 スミスクライン・ビーチャム・コーポレイション キトトリオシダーゼ

Also Published As

Publication number Publication date
AU731203B2 (en) 2001-03-29
US6372212B1 (en) 2002-04-16
CZ403598A3 (cs) 1999-07-14
EP0918870A1 (en) 1999-06-02
BR9709721A (pt) 1999-08-10
HUP0001644A2 (hu) 2000-09-28
CA2257829A1 (en) 1997-12-18
PL337060A1 (en) 2000-07-31
HUP0001644A3 (en) 2002-09-30
WO1997047752A1 (en) 1997-12-18
NO985806L (no) 1999-02-11
NO985806D0 (no) 1998-12-11
SK169798A3 (en) 2000-03-13
IL127568A0 (en) 1999-10-28
US20030017570A1 (en) 2003-01-23
AU3397897A (en) 1998-01-07
CN1236393A (zh) 1999-11-24

Similar Documents

Publication Publication Date Title
US6399571B1 (en) Chitinase chitin-binding fragments
Chaffin Candida albicans cell wall proteins
JP4177453B2 (ja) 組織因子活性インヒビターｔｆｐｉおよびｔｆｐｉ−２のキメラタンパク質および変異体
US5728381A (en) Glycosylation variants of iduronate 2-sulfatase
JP2000506385A (ja) 新規ｅｒａ
JPH11137267A (ja) 新規化合物
JP2001526183A (ja) ヒアルロニダーゼアイソザイムの精製およびミクロシークエンシング
JP2001510989A (ja) 新規コーディング配列
JP2001510325A (ja) キチナーゼ物質及び方法
JPH11137275A (ja) 新規グリコーゲンホスホリラーゼ
JPH11507816A (ja) 再生している肝臓においてアップレギュレートされた新規な遺伝子
JPH08509380A (ja) ヒトＳｙｋ
JPH11243969A (ja) 新規ＭｕｒＤ
JPH11192091A (ja) ＳｅｃＡ
JP2000000098A (ja) 新規ｅｒａ
MXPA98010619A (en) Materials and methods for the production of quitin
JPH11155582A (ja) 新規ＧｌｍＵ
CZ20003308A3 (cs) Chitin-vazebné fragmenty chitinázy
RU2143491C1 (ru) Полинуклеотидная последовательность (варианты), полипептид (варианты), слитый белок, фармацевтическая композиция, моноклональное антитело, штамм гибридных культивируемых клеток
WO2018230628A1 (ja) ファブリー病治療用医薬の組合せ物及びその利用
JP2003504030A (ja) 新規抗真菌剤および殺菌剤、その製造および使用法
JPH11235182A (ja) 新規化合物
JPH1175877A (ja) 新規化合物
JPH10304884A (ja) 新規ｒａｔ
JPH11151095A (ja) 新規ヒスチジンキナーゼ

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061121

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070413

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070522